Endometriosis associated infertility: ESHRE2022

Aboubakr Elnashar
Aboubakr ElnasharProfessor Obstetrics and Gynecology à Aboubakr Mohamed Elnashar
3/15/2022
ABOUBAKR ELNASHAR
You can get this lecture and 500 lecture from:
1.My scientific page on Face book: Aboubakr
Elnashar Lectures.
https://www.facebook.com/groups/2277448840913
51/
2.Slide share web site
3.elnashar53@hotmail.com
4.My clinic: Elthawra St. Mansura
TREATMENT OF
ENDOMETRIOSIS-ASSOCIATED INFERTILITY
ESHRE guidelines 2022
Prof. ABOUBAKR ELNASHAR
Benha university Hospital, Egypt
ABOUBAKRELNASHAR
ABOUBAKRELNASHAR
CONTENTS
I. DIAGNOSIS OF ENDOMETRIOSIS
II. TREATMENT OF ENDOMETRIOSIS-ASSOCIATED PAIN
III. TREATMENT OF ENDOMETRIOSIS-ASSOCIATED
INFERTILITY
IV. IMPACT OF ENDOMETRIOSIS ON PREGNANCY AND PREGNANCY OUTCOME
V. ENDOMETRIOSIS RECURRENCE
VI. ENDOMETRIOSIS AND ADOLESCENCE
VII. ENDOMETRIOSIS AND MENOPAUSE
VIII.EXTRAPELVIC ENDOMETRIOSIS
IX. ASYMPTOMATIC ENDOMETRIOSIS
X. PRIMARY PREVENTION OF ENDOMETRIOSIS
XI. ENDOMETRIOSIS AND CANCER
ABOUBAKRELNASHAR
 Recommendations either ‘‘strong’’ or ‘‘weak” according to the GRADE
approach,
ABOUBAKRELNASHAR
DIAGNOSIS OF ENDOMETRIOSIS
 Symptoms
 Cyclical & non-cyclical:
 Dysmenorrhea,
 Deep dyspareunia ,
 Infertility
 Dysuria
 Dyschezia
 Painful rectal bleeding or
haematuria,
 shoulder tip pain,
 catamenial pneumothorax,
cyclical cough/haemoptysis/
chest pain, cyclical scar swelling
and pain, fatigue. GPP
ABOUBAKRELNASHAR
3/15/2022
 Diary/questionnaire/app
 No evidence that a symptom reduces the time to diagnosis or
leads to earlier diagnosis
 Potential benefit in
 completing the traditional history
 pain
 Other symptoms. GDG STATEMENT
 Clinical examination, including vaginal examination
 should be considered to identify
 deep nodules or
 endometriomas in patients with suspected endometriosis
 Diagnostic accuracy is low.⊕Strong recommendation
ABOUBAKRELNASHAR
 Investigation
 Biomarkers: not to be used.⊕⊕⊕ Strong recommendation
1. Imaging (US or MRI):
 Should be considered even if the clinical
examination is normal.⊕⊕ Strong recommendation
 Negative finding does not exclude endometriosis,
particularly superficial peritoneal disease ⊕⊕Strong
recommendation
ABOUBAKRELNASHAR
 Justification:
 For endometrioma & DIE: TVS & MRI have a similar
or slightly better specificity & sensitivity than
laparoscopy
 For superficial disease: imaging modalities have
inferior diagnostic value compared to laparoscopy
(Wykes, et al., 2004).
 Dedicated TVS in experienced hands (also MRI)
 can replace laparoscopy
 the gold standard for the diagnosis of
endometrioma & DIE in the pelvis
ABOUBAKRELNASHAR
2. Laparoscopy is considered for the diagnosis &TT in
1. Patients with negative imaging results
2. Empirical TT was unsuccessful or inappropriate GPP
 Endometriotic lesions is confirmed by histology although
negative histology does not entirely rule out the disease GPP
 Justification:
 The benefits of laparoscopy need to be weighed up
against its risks (Bafort, et al., 2020, Byrne, et al., 2018b, Chapron, et
al., 1998).
 Expensive, invasive& associated with morbidity mortality.
 Direct, photographic& histological proof of lesions: an
important psychological factor for women
ABOUBAKRELNASHAR
 2-step approach
 Can be considered
 endometriosis is suspected
 imaging results are negative
 not trying to conceive
 TVS followed by empirical TT
 oral contraceptive pill or progestogens(Kuznetsov, et
al., 2017).
 If symptoms improve: endometriosis is presumed
the main underlying condition, although other
clinical causes can coexist.
ABOUBAKRELNASHAR
 Women suspected of endometriosis
 Diagnostic laparoscopy and
 Imaging combined with empirical TT
 Can be considered
 No evidence of superiority of either approach:
 Pros & cons should be discussed with the
patient. GDG STATEMENT
ABOUBAKRELNASHAR
3/15/2022
TREATMENT OF ENDOMETRIOSIS-ASSOCIATED
INFERTILITY
 LINES OF TREATMENT
I. IUI & OS
II. SURGERY
III. IVF
IV. FERTILITY PRESERVATION
 Medical
 Non medical
ABOUBAKRELNASHAR
 Medical treatment
 Ovarian suppression Should not be prescribed to
improve fertility ⊕⊕Strong recommendation
 Justification:
 Based on the results of the Cochrane review, suppression of ovarian
function (by means of danazol, GnRH agonists, progestogens, OCP)
to improve fertility is not effective and should not be offered for this
indication alone
 Pentoxifylline, other anti-inflammatory drugs or
letrozole outside ovulation-induction: should not
prescribed to improve natural pregnancy rates
⊕Strong recommendation
ABOUBAKRELNASHAR
 Justification
 As endometriosis is associated with inflammation.
Pentoxifylline has anti‐inflammatory properties.
 SR show no benefit of pentoxifylline, postoperative
aromatase inhibitor (letrozole), or postoperative
GnRH agonist (triptorelin) to improve pregnancy
rates in women with endometriosis.
ABOUBAKRELNASHAR
 Non-medical management strategies for infertility
 Nutrition, Chinese medicine,
 Electrotherapy, acupuncture
 Physiotherapy, exercise, and psychological
interventions
 No clear evidence of benefit to increase the
chance of pregnancy.
 No recommendation can be made to support
any to increase fertility.
 The potential benefits and harms are unclear
GDG STATEMENT
ABOUBAKRELNASHAR
I. IUI with ovarian stimulation:
 rASRM stage I/II, instead of expectant
management or IUI alone, as it increases PR
⊕Weak recommendation
 could be considered in rASRM stage III/IV with
tubal patency Although the value is uncertain
⊕Weak recommendation
ABOUBAKRELNASHAR
II. SURGERY
 Should be guided by
 Presence or absence of pain symptoms
 Patient age and preferences
 History of previous surgery
 Presence of other infertility factors
 Ovarian reserve
 Estimated Endometriosis Fertility Index (EFI)
GPP
 Women should be counselled of their chances of
becoming pregnant after surgery.
ABOUBAKRELNASHAR
3/15/2022
ABOUBAKRELNASHAR
 Operative laparoscopy
 For rASRM stage I/II could be offered {improves the
rate of ongoing pregnancy} ⊕⊕Weak recommendation
 For endometrioma-associated infertility May be
considered {may increase their chance of natural
pregnancy}, although no data from comparative
studies exist ⊕ Weak recommendation
 For deep endometriosis: No convincing evidence
exists that it improves fertility
 May represent TT option in symptomatic patients
wishing to conceive ⊕Weak recommendation
ABOUBAKRELNASHAR
 Postoperative hormone suppression
 Should not be prescribed with the sole purpose to
enhance future pregnancy rates ⊕⊕Strong
recommendation
 may be offered for women who cannot attempt to
or decide not to conceive immediately after surgery
{does not negatively impact their fertility and
improves the immediate outcome of surgery for
pain} ⊕⊕ Weak recommendation
ABOUBAKRELNASHAR
III. ART
 Can be performed especially if
1. Tubal function is compromised
2. Male factor infertility
3. Low EFI and/or
4. Other treatments have failed ⊕⊕ Weak recommendation
 To identify patients that may benefit from ART after surgery
 EFI should be used as it is validated,
reproducible and cost-effective.
 Other fertility investigations such as their
partner’s sperm analysis GDG STATEMENT
ABOUBAKRELNASHAR
 Surgery prior ART
 rASRM stage I/II endometriosis: Not recommended as the
potential benefits are unclear ⊕⊕Strong recommendation
 Endometrioma
 Not recommended {no benefit& surgery is likely to have
a negative impact on ovarian reserve}. ⊕⊕Strong
recommendation
 can be considered to improve endometriosis-associated
pain or accessibility of follicles GPP
 Deep endometriosis: should be guided mainly by pain
symptoms& patient preference as its effectiveness on
reproductive outcome is uncertain due to lack of RCT
⊕Strong recommendation
ABOUBAKRELNASHAR
 Protocol
 Both GnRHan & agonist can be offered based on
patients’& physicians’ preferences as no difference
in PR or LBR ⊕ Weak recommendation
 The extended GnRHa is not recommended, as the
benefit is uncertain ⊕Strong recommendation
 Insufficient evidence to recommend prolonged
administration of COC/progestogens as a pre-TT to
ART to increase LPR ⊕ Weak recommendation
 The data are very limited and do not allow to draw any conclusion.
 This does not preclude use of OCP for planning purposes.
ABOUBAKRELNASHAR
3/15/2022
 Oocyte retrieval
 In women with endometrioma, clinicians may use
antibiotic prophylaxis
 Although the risk of ovarian abscess formation
following follicle aspiration is low GPP
 Recurrence rates are not increased compared to
those women not undergoing ART ⊕⊕⊕ Weak
recommendation
ABOUBAKRELNASHAR
IV. Fertility Preservation (FP): oocyte cryopreservation
 In case of extensive ovarian endometriosis,
clinicians should discuss the pros & cons of FP
 The true benefit of FP is unknown ⊕ Strong recommendation
 FP may increase future chances of pregnancy of some
women
 FP is expensive& ±some clinical risks.
 Still many questions remain unanswered
 Cost effectiveness
 Criteria to select those women.
 Strong recommendation for counselling& information
provision.
ABOUBAKRELNASHAR
ABOUBAKRELNASHAR ABOUBAKR ELNASHAR
You can get this lecture and 500 lecture from:
1.My scientific page on Face book: Aboubakr
Elnashar Lectures.
https://www.facebook.com/groups/2277448840913
51/
2.Slide share web site
3.elnashar53@hotmail.com
4.My clinic: Elthawra St. Mansura
1 sur 3

Contenu connexe

Tendances(20)

Role of IUI in the era of IVFRole of IUI in the era of IVF
Role of IUI in the era of IVF
Sujoy Dasgupta1.1K vues
Intrauterine Insemination UPDATE 2018 Intrauterine Insemination UPDATE 2018
Intrauterine Insemination UPDATE 2018
Lifecare Centre7.2K vues
Fibroid and infertilityFibroid and infertility
Fibroid and infertility
Aboubakr Elnashar7K vues
Ovulation Stimulation Protocols for IUIOvulation Stimulation Protocols for IUI
Ovulation Stimulation Protocols for IUI
Bharati Dhorepatil4.4K vues
Unexplained infertilityUnexplained infertility
Unexplained infertility
Aboubakr Elnashar7K vues
Art f reductionArt f reduction
Art f reduction
Aboubakr Elnashar5.1K vues
Thin Endometrium & InfertilityThin Endometrium & Infertility
Thin Endometrium & Infertility
Lifecare Centre8K vues
Endometriosis and InfertilityEndometriosis and Infertility
Endometriosis and Infertility
Sujoy Dasgupta1.8K vues
Uterus preserving surgeries for prolapseUterus preserving surgeries for prolapse
Uterus preserving surgeries for prolapse
Rajesh Gajbhiye11.5K vues
Difficult Cases in IUIDifficult Cases in IUI
Difficult Cases in IUI
Sujoy Dasgupta337 vues
How to reduce cs rate slideshareHow to reduce cs rate slideshare
How to reduce cs rate slideshare
Mahmoud Abdel-Aleem2.7K vues
Optimizing IUI OutcomeOptimizing IUI Outcome
Optimizing IUI Outcome
Dr.Laxmi Agrawal Shrikhande948 vues

Similaire à Endometriosis associated infertility: ESHRE2022(20)

Plus de Aboubakr Elnashar

hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdfAboubakr Elnashar
1.5K vues5 diapositives
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdfAboubakr Elnashar
373 vues5 diapositives

Plus de Aboubakr Elnashar(20)

hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
Aboubakr Elnashar1.5K vues
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
Aboubakr Elnashar373 vues
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
Aboubakr Elnashar489 vues
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
Aboubakr Elnashar490 vues
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
Aboubakr Elnashar1.8K vues
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
Aboubakr Elnashar1.5K vues
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
Aboubakr Elnashar1.2K vues
Infertility prevention Infertility prevention
Infertility prevention
Aboubakr Elnashar920 vues
Maternal near missMaternal near miss
Maternal near miss
Aboubakr Elnashar1.6K vues
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
Aboubakr Elnashar1.4K vues
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
Aboubakr Elnashar3.3K vues
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
Aboubakr Elnashar1.2K vues
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
Aboubakr Elnashar1.1K vues
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
Aboubakr Elnashar3.3K vues
Imaging in pregnancy 2 in1Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1
Aboubakr Elnashar1.2K vues
update on PCOSupdate on PCOS
update on PCOS
Aboubakr Elnashar3.1K vues
PREECLAMPSIA‐ECLAMPSIA SPECTRUMPREECLAMPSIA‐ECLAMPSIA SPECTRUM
PREECLAMPSIA‐ECLAMPSIA SPECTRUM
Aboubakr Elnashar1.4K vues

Endometriosis associated infertility: ESHRE2022

  • 1. 3/15/2022 ABOUBAKR ELNASHAR You can get this lecture and 500 lecture from: 1.My scientific page on Face book: Aboubakr Elnashar Lectures. https://www.facebook.com/groups/2277448840913 51/ 2.Slide share web site 3.elnashar53@hotmail.com 4.My clinic: Elthawra St. Mansura TREATMENT OF ENDOMETRIOSIS-ASSOCIATED INFERTILITY ESHRE guidelines 2022 Prof. ABOUBAKR ELNASHAR Benha university Hospital, Egypt ABOUBAKRELNASHAR ABOUBAKRELNASHAR CONTENTS I. DIAGNOSIS OF ENDOMETRIOSIS II. TREATMENT OF ENDOMETRIOSIS-ASSOCIATED PAIN III. TREATMENT OF ENDOMETRIOSIS-ASSOCIATED INFERTILITY IV. IMPACT OF ENDOMETRIOSIS ON PREGNANCY AND PREGNANCY OUTCOME V. ENDOMETRIOSIS RECURRENCE VI. ENDOMETRIOSIS AND ADOLESCENCE VII. ENDOMETRIOSIS AND MENOPAUSE VIII.EXTRAPELVIC ENDOMETRIOSIS IX. ASYMPTOMATIC ENDOMETRIOSIS X. PRIMARY PREVENTION OF ENDOMETRIOSIS XI. ENDOMETRIOSIS AND CANCER ABOUBAKRELNASHAR  Recommendations either ‘‘strong’’ or ‘‘weak” according to the GRADE approach, ABOUBAKRELNASHAR DIAGNOSIS OF ENDOMETRIOSIS  Symptoms  Cyclical & non-cyclical:  Dysmenorrhea,  Deep dyspareunia ,  Infertility  Dysuria  Dyschezia  Painful rectal bleeding or haematuria,  shoulder tip pain,  catamenial pneumothorax, cyclical cough/haemoptysis/ chest pain, cyclical scar swelling and pain, fatigue. GPP ABOUBAKRELNASHAR 3/15/2022  Diary/questionnaire/app  No evidence that a symptom reduces the time to diagnosis or leads to earlier diagnosis  Potential benefit in  completing the traditional history  pain  Other symptoms. GDG STATEMENT  Clinical examination, including vaginal examination  should be considered to identify  deep nodules or  endometriomas in patients with suspected endometriosis  Diagnostic accuracy is low.⊕Strong recommendation ABOUBAKRELNASHAR  Investigation  Biomarkers: not to be used.⊕⊕⊕ Strong recommendation 1. Imaging (US or MRI):  Should be considered even if the clinical examination is normal.⊕⊕ Strong recommendation  Negative finding does not exclude endometriosis, particularly superficial peritoneal disease ⊕⊕Strong recommendation ABOUBAKRELNASHAR  Justification:  For endometrioma & DIE: TVS & MRI have a similar or slightly better specificity & sensitivity than laparoscopy  For superficial disease: imaging modalities have inferior diagnostic value compared to laparoscopy (Wykes, et al., 2004).  Dedicated TVS in experienced hands (also MRI)  can replace laparoscopy  the gold standard for the diagnosis of endometrioma & DIE in the pelvis ABOUBAKRELNASHAR 2. Laparoscopy is considered for the diagnosis &TT in 1. Patients with negative imaging results 2. Empirical TT was unsuccessful or inappropriate GPP  Endometriotic lesions is confirmed by histology although negative histology does not entirely rule out the disease GPP  Justification:  The benefits of laparoscopy need to be weighed up against its risks (Bafort, et al., 2020, Byrne, et al., 2018b, Chapron, et al., 1998).  Expensive, invasive& associated with morbidity mortality.  Direct, photographic& histological proof of lesions: an important psychological factor for women ABOUBAKRELNASHAR  2-step approach  Can be considered  endometriosis is suspected  imaging results are negative  not trying to conceive  TVS followed by empirical TT  oral contraceptive pill or progestogens(Kuznetsov, et al., 2017).  If symptoms improve: endometriosis is presumed the main underlying condition, although other clinical causes can coexist. ABOUBAKRELNASHAR  Women suspected of endometriosis  Diagnostic laparoscopy and  Imaging combined with empirical TT  Can be considered  No evidence of superiority of either approach:  Pros & cons should be discussed with the patient. GDG STATEMENT ABOUBAKRELNASHAR
  • 2. 3/15/2022 TREATMENT OF ENDOMETRIOSIS-ASSOCIATED INFERTILITY  LINES OF TREATMENT I. IUI & OS II. SURGERY III. IVF IV. FERTILITY PRESERVATION  Medical  Non medical ABOUBAKRELNASHAR  Medical treatment  Ovarian suppression Should not be prescribed to improve fertility ⊕⊕Strong recommendation  Justification:  Based on the results of the Cochrane review, suppression of ovarian function (by means of danazol, GnRH agonists, progestogens, OCP) to improve fertility is not effective and should not be offered for this indication alone  Pentoxifylline, other anti-inflammatory drugs or letrozole outside ovulation-induction: should not prescribed to improve natural pregnancy rates ⊕Strong recommendation ABOUBAKRELNASHAR  Justification  As endometriosis is associated with inflammation. Pentoxifylline has anti‐inflammatory properties.  SR show no benefit of pentoxifylline, postoperative aromatase inhibitor (letrozole), or postoperative GnRH agonist (triptorelin) to improve pregnancy rates in women with endometriosis. ABOUBAKRELNASHAR  Non-medical management strategies for infertility  Nutrition, Chinese medicine,  Electrotherapy, acupuncture  Physiotherapy, exercise, and psychological interventions  No clear evidence of benefit to increase the chance of pregnancy.  No recommendation can be made to support any to increase fertility.  The potential benefits and harms are unclear GDG STATEMENT ABOUBAKRELNASHAR I. IUI with ovarian stimulation:  rASRM stage I/II, instead of expectant management or IUI alone, as it increases PR ⊕Weak recommendation  could be considered in rASRM stage III/IV with tubal patency Although the value is uncertain ⊕Weak recommendation ABOUBAKRELNASHAR II. SURGERY  Should be guided by  Presence or absence of pain symptoms  Patient age and preferences  History of previous surgery  Presence of other infertility factors  Ovarian reserve  Estimated Endometriosis Fertility Index (EFI) GPP  Women should be counselled of their chances of becoming pregnant after surgery. ABOUBAKRELNASHAR 3/15/2022 ABOUBAKRELNASHAR  Operative laparoscopy  For rASRM stage I/II could be offered {improves the rate of ongoing pregnancy} ⊕⊕Weak recommendation  For endometrioma-associated infertility May be considered {may increase their chance of natural pregnancy}, although no data from comparative studies exist ⊕ Weak recommendation  For deep endometriosis: No convincing evidence exists that it improves fertility  May represent TT option in symptomatic patients wishing to conceive ⊕Weak recommendation ABOUBAKRELNASHAR  Postoperative hormone suppression  Should not be prescribed with the sole purpose to enhance future pregnancy rates ⊕⊕Strong recommendation  may be offered for women who cannot attempt to or decide not to conceive immediately after surgery {does not negatively impact their fertility and improves the immediate outcome of surgery for pain} ⊕⊕ Weak recommendation ABOUBAKRELNASHAR III. ART  Can be performed especially if 1. Tubal function is compromised 2. Male factor infertility 3. Low EFI and/or 4. Other treatments have failed ⊕⊕ Weak recommendation  To identify patients that may benefit from ART after surgery  EFI should be used as it is validated, reproducible and cost-effective.  Other fertility investigations such as their partner’s sperm analysis GDG STATEMENT ABOUBAKRELNASHAR  Surgery prior ART  rASRM stage I/II endometriosis: Not recommended as the potential benefits are unclear ⊕⊕Strong recommendation  Endometrioma  Not recommended {no benefit& surgery is likely to have a negative impact on ovarian reserve}. ⊕⊕Strong recommendation  can be considered to improve endometriosis-associated pain or accessibility of follicles GPP  Deep endometriosis: should be guided mainly by pain symptoms& patient preference as its effectiveness on reproductive outcome is uncertain due to lack of RCT ⊕Strong recommendation ABOUBAKRELNASHAR  Protocol  Both GnRHan & agonist can be offered based on patients’& physicians’ preferences as no difference in PR or LBR ⊕ Weak recommendation  The extended GnRHa is not recommended, as the benefit is uncertain ⊕Strong recommendation  Insufficient evidence to recommend prolonged administration of COC/progestogens as a pre-TT to ART to increase LPR ⊕ Weak recommendation  The data are very limited and do not allow to draw any conclusion.  This does not preclude use of OCP for planning purposes. ABOUBAKRELNASHAR
  • 3. 3/15/2022  Oocyte retrieval  In women with endometrioma, clinicians may use antibiotic prophylaxis  Although the risk of ovarian abscess formation following follicle aspiration is low GPP  Recurrence rates are not increased compared to those women not undergoing ART ⊕⊕⊕ Weak recommendation ABOUBAKRELNASHAR IV. Fertility Preservation (FP): oocyte cryopreservation  In case of extensive ovarian endometriosis, clinicians should discuss the pros & cons of FP  The true benefit of FP is unknown ⊕ Strong recommendation  FP may increase future chances of pregnancy of some women  FP is expensive& ±some clinical risks.  Still many questions remain unanswered  Cost effectiveness  Criteria to select those women.  Strong recommendation for counselling& information provision. ABOUBAKRELNASHAR ABOUBAKRELNASHAR ABOUBAKR ELNASHAR You can get this lecture and 500 lecture from: 1.My scientific page on Face book: Aboubakr Elnashar Lectures. https://www.facebook.com/groups/2277448840913 51/ 2.Slide share web site 3.elnashar53@hotmail.com 4.My clinic: Elthawra St. Mansura